TABLE 3.

Maximal SBP elevations by the duration and number of events following bremelanotide and placebo

Treatment arms	SBP > 150 mmHg				SBP > 160 mmHg				SBP > 170 mmHg				SBP > 180 mmHg
	Number of events by event duration (min)
	<15	>15	>30	>45	<15	>15	>30	>45	<15	>15	>30	>45	<15	>15	>30	>45
Placebo	11	2	0	0	7	0	0	0	2	0	0	0	0	0	0	0
0.75 mg	22	1	0	0	3	0	0	0	2	1	0	0	1	0	0	0
1.25 mg	14	2	2	1	6	0	0	0	2	0	0	0	1	0	0	0
1.75 mg	17	0	1	0	12	1	0	0	0	1	1	0	0	0	0	0